FR2796280B1 - Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique - Google Patents

Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique

Info

Publication number
FR2796280B1
FR2796280B1 FR9909174A FR9909174A FR2796280B1 FR 2796280 B1 FR2796280 B1 FR 2796280B1 FR 9909174 A FR9909174 A FR 9909174A FR 9909174 A FR9909174 A FR 9909174A FR 2796280 B1 FR2796280 B1 FR 2796280B1
Authority
FR
France
Prior art keywords
vip
agonists
antagonists
modulate
initiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9909174A
Other languages
English (en)
Other versions
FR2796280A1 (fr
Inventor
Pascale Jeannin
Yves Delneste
Marc Vittori
Jean Yves Bonnefoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR9909174A priority Critical patent/FR2796280B1/fr
Priority to PCT/FR2000/002037 priority patent/WO2001005423A1/fr
Priority to AU65757/00A priority patent/AU6575700A/en
Publication of FR2796280A1 publication Critical patent/FR2796280A1/fr
Application granted granted Critical
Publication of FR2796280B1 publication Critical patent/FR2796280B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/35—Vasoactive intestinal peptide [VIP]; Pituitary adenylate cyclase activating polypeptide [PACAP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9909174A 1999-07-15 1999-07-15 Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique Expired - Fee Related FR2796280B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9909174A FR2796280B1 (fr) 1999-07-15 1999-07-15 Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique
PCT/FR2000/002037 WO2001005423A1 (fr) 1999-07-15 2000-07-13 Utilisation du peptide intestinal vasoactif (vip) pour moduler le developpement d'une reponse immune specifique
AU65757/00A AU6575700A (en) 1999-07-15 2000-07-13 Use of vasoactive intestinal peptide (vip) for modulating the development of a specific immune response

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909174A FR2796280B1 (fr) 1999-07-15 1999-07-15 Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique

Publications (2)

Publication Number Publication Date
FR2796280A1 FR2796280A1 (fr) 2001-01-19
FR2796280B1 true FR2796280B1 (fr) 2001-10-26

Family

ID=9548127

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9909174A Expired - Fee Related FR2796280B1 (fr) 1999-07-15 1999-07-15 Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique

Country Status (3)

Country Link
AU (1) AU6575700A (fr)
FR (1) FR2796280B1 (fr)
WO (1) WO2001005423A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0427267D0 (en) * 2004-12-13 2005-01-12 Maria Teresa De Magistris Peptide adjuvants
ES2315081B1 (es) * 2006-03-15 2009-12-30 Grup D'afectats D'esclerosi Multiple (Gaem) Nuevo uso del peptido intestinal vasoactivo (vip) y de las celulas aisladas estimuladas con dicho peptido.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05238950A (ja) * 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性ｖｉｐ製剤

Also Published As

Publication number Publication date
WO2001005423A1 (fr) 2001-01-25
AU6575700A (en) 2001-02-05
FR2796280A1 (fr) 2001-01-19

Similar Documents

Publication Publication Date Title
BR9608032A (pt) Sulfonamidas contendo thf inibidoras de aspartil protease
DZ2444A1 (fr) Bonde à goupille dilatable pour l'utilisation automatisée.
GR3036889T3 (en) Reestablishment of call after disconnect.
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
ZA96940B (en) Substituted biphenyl sulfonamide edothelin antagonists.
DE69731674D1 (de) Silencieux d'aspiration pour compresseur
MA24629A1 (fr) 4-AMINOPYRROLE (3,2-d) PYRIMIDINES SERVANT D'ANTAGONISTES DES RECEPTEURS DE NEUROPEPTIDE Y.
SG46218A1 (en) Substituted biphenyl sulfonamide endothelin antagonists
TR199802624A3 (tr) Yeni farmasötik.
FR2761130B1 (fr) Dispositif a soufflet, son application a un joint de transmission, et bague pour un tel dispositif
FR2760506B1 (fr) Bague d'etancheite activee par pression
DK0855000T3 (da) Væskedrejeforbindelsesdel
FR2762377B1 (fr) Dispositif d'etancheite pour jonctions de tuyaux
ZA983244B (en) Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydroisoquinolin-6-yl)-amide.
IT1313191B1 (it) Procedimento per l'applicazione di uno strato antigraffio e di unsistema di strati antiriflessione e dispositivo per la sua esecuzione.
FR2796280B1 (fr) Nouvelle utilisation du vasoactive intestinal peptide (vip), de ses agonistes et de ses antagonistes pour moduler le developpement/initiation d'une reponse immune specifique
TR199600932T1 (tr) Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
EP0870198A4 (fr) Recepteur recombinant de c140, ses agonistes et antagonistes et acides nucleiques codant le recepteur
FR2675879B1 (fr) Dispositif pour supporter une tuyauterie au passage d'une cloison et assurer l'etancheite de part et d'autres de la cloison.
FR2760264B1 (fr) Dispositif d'etanchement
FR2652872B1 (fr) Raccord pour tuyau.
FR2741535B1 (fr) Nouvelles preparations pour la sphere bucco-pharyngee
FR2742824B1 (fr) Joint d'etancheite pour joint homocinetique
FR2766851B1 (fr) Ossatures pour la construction d'un batiment

Legal Events

Date Code Title Description
ST Notification of lapse